Star Lake Bioscience Co (SHSE:600866) Net Issuance of Preferred Stock : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Star Lake Bioscience Co's net issuance of preferred for the three months ended in Mar. 2024 was ¥0 Mil. The number is 0, which means that Star Lake Bioscience Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Star Lake Bioscience Co's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Star Lake Bioscience Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Star Lake Bioscience Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Net Issuance of Preferred Stock Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Star Lake Bioscience Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Star Lake Bioscience Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines